NCT01447758 Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis. Status TERMINATED Phase PHASE1
NCT01428297 A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome Status COMPLETED Phase PHASE1
NCT01423656 Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102 Status COMPLETED Phase PHASE1
NCT01402414 Narrow-band (NB)-UVB vs. Bath-PUVA and NB-UVB Plus Salt Water Baths in Atopic Dermatitis Status TERMINATED Phase NA
NCT01385657 Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT01375205 Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants Status COMPLETED Phase NA
NCT01359787 Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD) Status COMPLETED Phase PHASE2
NCT01356758 Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents Status COMPLETED Phase N/A
NCT01326910 Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema Status COMPLETED Phase NA
NCT01320579 Investigation of the Efficacy of 2.5% and 5% Cis-urocanic Acid in Patients With Moderate or Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT01311986 Chemokine Expression in Nummular Dermatitis and Atopic Dermatitis Status UNKNOWN Phase N/A